BTLA and PD-1 combined with radiotherapy for enhancing antitumor immune response in lung cancer via the regulation of memory B cells to promote T-cell infiltration. [PDF]
Zhang Y +10 more
europepmc +1 more source
STC1 is associated with tumor progression and suppressive niches in laryngeal squamous cell carcinoma. [PDF]
Chen X +6 more
europepmc +1 more source
Triple-Negative Breast Cancer: Molecular Subtypes; Immune Escape; Limitations of Current Immunotherapy; and the BTLA/HVEM/CD160 Axis as an Emerging Target. [PDF]
Rapoport BL +6 more
europepmc +1 more source
Soluble immune checkpoints as diagnostic biomarkers in bladder cancer. [PDF]
Andrzejczak A +9 more
europepmc +1 more source
Efficacy and safety of venanprubart, a BTLA agonist antibody, in patients with active systemic lupus erythematosus. [PDF]
Ghosh I +8 more
europepmc +1 more source
Comprehensive bioinformatics analysis identifies DNA methylation signatures associated with immune evasion and predicts immunotherapy response in breast cancer. [PDF]
Cheng Y, Wang J, Yan D.
europepmc +1 more source
Soluble immune checkpoints reflect immune activation and treatment response in high-risk systemic sclerosis patients treated with plasma exchange. [PDF]
Potjewijd J +6 more
europepmc +1 more source
BTLA-mediated regulation of neuroimmune responses enhances recovery after intracerebral hemorrhage. [PDF]
Wu Y +14 more
europepmc +1 more source

